Remedent (OTCMKTS:REMI) vs. Cooper Companies (NASDAQ:COO): A Financial and Operational Comparison
This analysis compares Remedent,Inc. and The Cooper Companies,Inc., outlining their respective business operations and providing a snapshot of their current standing. While a direct financial comparison is limited due to Remedent’s over-the-counter (OTC) market status and limited public reporting, this overview highlights key differences and similarities.
Remedent, Inc. (OTCMKTS:REMI)
Founded in 1986 and headquartered in Ghent, Belgium, Remedent focuses on aesthetic dentistry and digital dental solutions. The company provides a range of products and services aimed at enhancing smiles, including minor tooth reshaping and GlamSmile veneers – ultra-thin dental claddings. beyond materials, Remedent offers integrated marketing tools for dental practices.These include SmileMe Mirror,a system for rapid smile consultations (approximately 10 minutes); SmileSketch,simulation software for visualizing potential patient outcomes; and Treatment Pages designed to educate patients on treatment benefits. remedent also provides Condor,an intra-oral 3D scanner,and dental implant solutions and associated treatment concepts. Remedent distributes it’s products through both a direct sales force and third-party distributors. As an OTC-traded company,detailed financial data is less readily available than for publicly listed entities.
The Cooper Companies, Inc. (NASDAQ:COO)
Established in 1958 and based in San Ramon, California, Cooper Companies is a significantly larger and more diversified organization. It operates through two primary segments: CooperVision and CooperSurgical.
* CooperVision develops, manufactures, and markets contact lenses, including spherical lenses for nearsightedness and farsightedness, as well as toric and multifocal lenses addressing astigmatism, presbyopia, and myopia. These lenses are sold across the Americas, Europe, the Middle East, Africa, and asia Pacific.
* CooperSurgical concentrates on family and women’s health care. This segment offers fertility products and services, medical devices, and contraception. it also provides cryostorage solutions for cord blood and tissue. Specific products include endometrial imaging systems, devices for cesarean sections, illuminated speculums, IUDs, and a range of fertility consumables, equipment, and genetic testing services.
Cooper Companies distributes its products through a broad network including distributors, group purchasing organizations, eye care and health care professionals (independent practices, corporate retailers, hospitals, and clinics), and authorized resellers.
Key Differences & Financial Context
The most significant difference lies in scale and market focus. Cooper Companies is a large, publicly traded company (NASDAQ:COO) with a diversified portfolio in vision care and women’s health. Remedent is a smaller, privately-held company specializing in aesthetic dentistry and digital dental technology.
Cooper Companies’ publicly available financial reports (accessible via MarketBeat.com and other financial news sources) demonstrate a substantial revenue stream and established market position.Remedent, as an OTC-traded company, does not have the same level of financial openness. This makes a direct comparison of revenue, profitability, and growth rates challenging.
In conclusion: While both companies operate within the healthcare sector, they serve distinct niches.Cooper Companies is a broad-based healthcare provider with significant market capitalization, while Remedent is a specialized provider of aesthetic dental solutions. Investors interested in Remedent should exercise caution and conduct thorough due diligence given the limited publicly available financial information.
Disclaimer: This analysis is based on publicly available information as of October 26,2025,and should not be considered financial advice. Investors should consult with a qualified financial advisor before making any investment decisions.
